# Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).

> **NCT02820350** · NA · COMPLETED · sponsor: **CytoPherx, Inc** · enrollment: 19 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DEVICE:** SCD-F40

## Key facts

- **NCT ID:** NCT02820350
- **Lead sponsor:** CytoPherx, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-04
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02820350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02820350, "Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02820350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*